Eli Lilly and Company (LLY) News Today $767.76 +10.22 (+1.35%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Is Now a Good Time to Buy the Dip in Eli Lilly Stock?December 21 at 4:55 AM | fool.comEli Lilly and Company (NYSE:LLY) Shares Bought by M&T Bank CorpM&T Bank Corp lifted its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 0.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 266,822 shares of the company's stock after acquiDecember 21 at 4:10 AM | marketbeat.comThe FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be nextDecember 21 at 12:09 AM | yahoo.comFDA approves Eli Lilly’s obesity medication for obstructive sleep apneaDecember 21 at 12:09 AM | abcnews.go.comIn weight loss battle, Novo and Lilly face growing offensive from licensed copiesDecember 20 at 7:08 PM | msn.comEli Lilly Says FDA Approves Zepbound for Obstructive Sleep Apnea in Adults With ObesityDecember 20 at 7:08 PM | msn.comZepbound Approved For Sleep ApneaDecember 20 at 7:02 PM | forbes.comLilly's weight-loss drug Zepbound wins US FDA approval for sleep apneaDecember 20 at 4:42 PM | reuters.comFDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.December 20 at 4:39 PM | cnbc.comFDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesityDecember 20 at 4:32 PM | prnewswire.comEli Lilly and Company (NYSE:LLY) Trading 4.2% Higher - Here's WhyEli Lilly and Company (NYSE:LLY) Trading Up 4.2% - What's Next?December 20 at 2:12 PM | marketbeat.comFDA Says Shortage of Eli Lilly’s Zepbound Is Over, but Gives Compounders a Grace PeriodDecember 20 at 2:08 PM | msn.comEli Lilly and Company (NYSE:LLY) Shares Gap Up - Here's What HappenedEli Lilly and Company (NYSE:LLY) Shares Gap Up - Should You Buy?December 20 at 10:37 AM | marketbeat.comNovo obesity data ‘nearly a best-case’ for Eli Lilly, says CitiDecember 20 at 9:03 AM | tipranks.comEli Lilly Stock Soars as FDA Ends Weight Loss Drug ShortageDecember 20 at 9:03 AM | tipranks.comNovo Nordisk’s new weight-loss drug works better, but not as well as expectedDecember 20 at 8:17 AM | marketwatch.comNovo Nordisk’s new weight-loss drug works better, but not as well as expectedDecember 20 at 8:17 AM | marketwatch.comIndiana Sees $39 Billion Worth of Projects Under Construction, an Industrial Info News AlertDecember 20 at 8:05 AM | businesswire.comNovo Nordisk Stock Crashes 22% After Disappoitning Obesity Drug Data. Eli Lilly Shares Soar.December 20 at 6:20 AM | barrons.comFocus: In weight loss battle, Novo and Lilly face growing offensive from licenced copiesDecember 19 at 8:03 PM | reuters.comJim Cramer on Eli Lilly and Company (LLY): ‘I See Things Going Back To Normal For Eli Lilly’December 19 at 4:46 PM | insidermonkey.comEli Lilly and Company (NYSE:LLY) Shares Down 1.2% - Here's WhyEli Lilly and Company (NYSE:LLY) Shares Down 1.2% - Time to Sell?December 19 at 2:52 PM | marketbeat.comEli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is overDecember 19 at 2:30 PM | investing.comHims & Hers falls after FDA ends shortage of Lilly weight loss drugDecember 19 at 10:39 AM | tipranks.comUS FDA says Lilly's weight-loss drug shortage resolvedDecember 19 at 10:12 AM | reuters.comFDA says Eli Lilly's weight loss drug Zepbound is no longer in shortageDecember 19 at 9:51 AM | cnbc.comZealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future OutlookDecember 19 at 7:08 AM | seekingalpha.comThese 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?December 19 at 5:26 AM | fool.comThis Is Huge News for Eli Lilly InvestorsDecember 19 at 4:44 AM | fool.comEli Lilly's Alzheimer's treatment approved in China (Dec. 17)December 19 at 2:34 AM | msn.comEli Lilly and Company (NYSE:LLY) Shares Down 0.2% - Here's What HappenedEli Lilly and Company (NYSE:LLY) Trading Down 0.2% - What's Next?December 18 at 2:42 PM | marketbeat.comScouting America Receives $30 million Grant from Lilly Endowment to Build Character in the Nation's Young PeopleDecember 18 at 1:03 PM | globenewswire.comThis Feels Like the Post-Pandemic Rally. 3 Stocks to Buy If It IsDecember 18 at 11:13 AM | 247wallst.comNovo Nordisk: A New Boost for GLP-1 Sales on the Horizon (LLY)Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.December 18 at 10:38 AM | marketbeat.comOzempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss DrugDecember 18 at 6:15 AM | fool.comGan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)December 18 at 6:01 AM | prnewswire.comEli Lilly Is Putting Dividend Growth Stocks to Shame With Yet Another Huge Increase to Its PayoutDecember 18 at 5:11 AM | fool.comEli Lilly's Alzheimer's treatment approved in ChinaDecember 17, 2024 | reuters.comEli Lilly’s Kisunla approved in China for Alzheimer’s Disease treatmentDecember 17, 2024 | tipranks.comLilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's DiseaseDecember 17, 2024 | prnewswire.comEli Lilly and Company (NYSE:LLY) Trading Down 0.3% - Should You Sell?Eli Lilly and Company (NYSE:LLY) Shares Down 0.3% - Here's What HappenedDecember 17, 2024 | marketbeat.comEli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030December 17, 2024 | 247wallst.com15 Billion Reasons to Love Eli Lilly Stock Right NowDecember 17, 2024 | fool.comEli Lilly & Co. stock outperforms competitors despite losses on the dayDecember 17, 2024 | marketwatch.comEli Lilly: A Rare Buying OpportunityDecember 17, 2024 | seekingalpha.comLilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in EgyptDecember 17, 2024 | prnewswire.comEli Lilly and Company (NYSE:LLY) Stock Price Up 0.2% - Still a Buy?Eli Lilly and Company (NYSE:LLY) Trading 0.2% Higher - Here's WhyDecember 16, 2024 | marketbeat.comEMA CHMP recommends Lilly’s Crohn’s therapy for EU approvalDecember 16, 2024 | msn.comInnovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland ChinaDecember 15, 2024 | prnewswire.com2 Brand-New Reasons to Buy Eli Lilly Stock Right Now, and 2 Reasons to Be CautiousDecember 15, 2024 | fool.com Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. LLY Media Mentions By Week LLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼0.620.61▲Average Medical News Sentiment LLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼5749▲LLY Articles Average Week Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LLY Stock Alerts